Patents by Inventor Luigina Romani

Luigina Romani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of the long pentraxin PTX3 for the prevention or treatment of viral diseases
    Patent number: 7910092
    Abstract: It is described the use of the long pentraxin PTX3 (PTX3) or one of its functional derivatives, for the preparation of a medicament for the prevention or treatment of viral diseases and/or for inhibiting virus activation.
    Type: Grant
    Filed: February 28, 2007
    Date of Patent: March 22, 2011
    Assignee: Tecnogen S.p.A.
    Inventors: Paolo Carminati, Marica Sassano, Francesco Bistoni, Luigina Romani, Silvia Bozza
  • USE OF IL-23 ANTAGONISTS FOR TREATMENT OF INFECTION
    Publication number: 20100291084
    Abstract: Methods and compositions comprising antagonists of IL-23 are provided for the treatment of infections, such as chronic bacterial, viral and fungal infections.
    Type: Application
    Filed: February 8, 2008
    Publication date: November 18, 2010
    Inventors: Manfred Kopf, Luigina Romani, Robert A. Kastelein, Alissa A. Chackerian
  • USE OF THYMOSIN ALPHA 1 FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASES
    Publication number: 20100004174
    Abstract: The invention concerns the use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases such as multiple sclerosis, and inflammatory bowel diseases such as Crohn's disease or ulcerative colitis.
    Type: Application
    Filed: September 27, 2007
    Publication date: January 7, 2010
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE
    Inventors: Luigina Romani, Francesco Bistoni, Enrico Garaci, Guido Rasi, Paola Sinbaldi Vallebona
  • USE OF THE LONG PENTRAXIN PTX3 FOR THE PREVENTION OR TREATMENT OF VIRAL DISEASES
    Publication number: 20090286726
    Abstract: It is described the use of the long pentraxin PTX3 (PTX3) or one of its functional derivatives, for the preparation of a medicament for the prevention or treatment of viral diseases and/or for inhibiting virus activation.
    Type: Application
    Filed: February 28, 2007
    Publication date: November 19, 2009
    Applicant: TECNOGEN S.P.A.
    Inventors: Paolo Carminati, Marica Sassano, Francesco Bistoni, Luigina Romani, Silvia Bozza
  • USE OF THYMOSIN ALPHA 1, ALONE OR IN COMBINATION WITH PTX3 OR GANCICLOVIR, FOR THE TREATMENT OF CYTOMEGALOVIRUS INFECTION
    Publication number: 20090275508
    Abstract: It is described the use of thymosin alpha 1 in combination with long pentraxin PTX3 or Ganciclovir, for the preparation of a medicament for the prevention or treatment of viral diseases and/or for inhibiting virus activation.
    Type: Application
    Filed: April 12, 2007
    Publication date: November 5, 2009
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Luigina Romani, Francesco Bistoni, Enrico Garaci
  • USE OF THYMOSIN ALPHA 1 FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION AND TREATMENT OF ALLERGIES
    Publication number: 20090270594
    Abstract: The invention concerns the use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of allergies
    Type: Application
    Filed: September 27, 2007
    Publication date: October 29, 2009
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE
    Inventors: Luigina Romani, Francesco Bistoni, Enrico Garaci, Guido Rasi, Paola Sinibaldi Vallebona
  • USE OF THYMOSIN ALPHA 1 FOR THE TREATMENT OF IMMUNOLOGICAL DISEASES
    Publication number: 20090155260
    Abstract: It is described the use of thymosin alpha 1 for preparing a medicament useful for the prevention or treatment of graft-versus-host disease or graft rejection reactions in organ transplantation, in a mammal subject, in which the cells, tissues or organs for transplant is selected from the group comprising: stem cells, hematopoietic stem cells, bone marrow, heart, liver, kidney, lung, pancreas, small intestine, cornea or skin.
    Type: Application
    Filed: November 17, 2008
    Publication date: June 18, 2009
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Luigina ROMANI, Francesco BISTONI, Enrico GARACI
  • Treatment of aspergillus infections with alpha thymosin peptides
    Publication number: 20070129292
    Abstract: A method for treating a human infected with Aspergillus by using thymosin alpha 1 as an immuno-stimulator in activating dendritic cells. The method is particularly useful in preventing an infection by Aspergillus in an immuno-compromised host being treated with a bone marrow transplantation.
    Type: Application
    Filed: March 29, 2004
    Publication date: June 7, 2007
    Applicant: SciClone Pharmaceuticals, Inc.
    Inventors: Guido Rasi, Enrico Garaci, Francesco Bistoni, Luigina Romani, Paolo Di Francesco